Epigenetic drugs and targets effective against the virus replicative cycle that will also help to design more effective therapies for the pandemic.
Proprietario: European Institute of Oncology
Epigenetic modulators for the treatment of the main symptoms of rare subtypes of Autism Spectrum Disorders
Methond which investigates classes of epigenetic modulators to treat ASD by tackling key mechanistic dysregulations that underlie its core symptoms.
Platform which allows to unbiasedly identify tumor-specific therapeutic antibodies, without prior knowledge of their target antigens.
Anti-tumor drugs capable of reversing the symptoms of 7Dup, considered paradigmatic of the entire autism spectrum.
Soluble protein for detecting cancer progression to help identify cancer patients eligible for anti-angiogenic treatment.
Identification of a new molecular circuit responsible for the metabolic plasticity of the tumor as a target for the treatment of tumors.